Le Lézard
Classified in: Health
Subject: SVY

Vision 2025 - Healthcare in the Smart Home


DUBLIN, July 16, 2018 /PRNewswire/ --

The "Vision 2025 - Healthcare in the Smart Home" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

This study covers the concept of a smart home delivering healthcare, including the services, framework and the technology stack. It also delineates all of the resident profiles and their individual health needs that a smart home must cater to. For each of the application segments mentioned earlier, it covers the features a smart home must have to provide services for those segments. In addition, regional trends and statistics on current connected home penetration across the world have been included.

Revenue forecasts for the overall smart home, as well as for the health and wellness ecosystem are provided. In addition to the ecosystem for a care delivering smart home, a spotlight on the key companies to watch in this space has been included. Finally, analyst commentary on business models, future evolution and a glimpse of the smart home providing care has been covered.

Smart homes are no longer an emerging concept. Consumers are not only warming up to the idea but also buying home automation products. Smart speakers seem to be the favorite, with sales jumping from a meager 6 million units in 2016 to a whopping 33.2 million units in 2017. The developing ecosystem of home automation products that each of these current smart speakers provides is encouraging the sale of related lighting, energy and home security products.

Growing alongside this trend is the potential for healthcare services to be provided in a smart home. In fact, several health services being can be integrated with existing smart home infrastructure: telehealth, remote patient monitoring, simple medication reminders, or answers to health information queries. But the true potential of a smart home that offers care lies in identifying the unique health needs of each individual residing in a home-from infants or the elderly-and serving those unique needs simultaneously.

In the future, the true smart home (which will evolve from the current connected home'), and the further evolved intelligent homes' will be able to do this with ease, and monitor the entire health and wellness of all residents enabling a proactive approach to care, instead of reactive. For now, the homes can serve the needs of aging-in-place, chronic disease management and post-acute care. Naturally, the current ecosystem is somewhat fragmented, operating in silos. However, a platform integration of multiple health-related services with other non-health, consumer related services will be the next step for most vendors serving this space; for example, motion sensors can automatically turn up the lights for senior grandmother in an aging-in-place scenario.

Key Issues Addressed

Key Topics Covered:

1. Executive Summary

2. Market Overview

3. Smart Homes for Healthcare

4. Smart Home User Profiles

5. Smart Home Healthcare Application Segments

6. Aging-in-Place Segment

7. Chronic Disease Management Segment

8. Post-Acute Care Segment

9. Maternal and Infant Health Segment

10. Care for Physically and Intellectually Disabled Segment

11. General Health and Wellness Segment

12. Health and the Smart Home - Future Concept Scenario

13. Regional Trends

14. Revenue Forecasts

15. Smart Home Healthcare Ecosystem

16. Business Models for Delivering Care in Smart Homes

17. The Future of Smart Homes and Healthcare - Growth Opportunities

18. The Last Word

19. Appendix

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/research/swszvr/vision_2025?w=5

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

at 06:50
Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved BEQVEZtm (fidanacogene elaparvovec-dzkt) for the treatment of adults with moderate to severe hemophilia B who currently use factor IX (FIX) prophylaxis...

at 06:08
The Annual General Meeting of Bioretec Ltd was held on 26 April 2024 in Tampere, Finland. The Annual General Meeting approved the financial statements for the financial year 1 January?31 December 2023 and resolved to discharge the members of the...

at 06:00
IDEAYA Biosciences, Inc. , a precision medicine oncology company committed to the discovery and development of targeted therapeutics, today announced that, on April 25, 2024, the Compensation Committee of IDEAYA's Board of Directors granted...

at 06:00
-- Diluted EPS of $2.16; Adjusted Diluted EPS of $2.26 ---- Increases 2024 Full Year Guidance -- 2024 adjusted diluted EPS of $2.26, up over 7% from $2.11 in the first quarter of 2023.Increases 2024 full year adjusted diluted EPS guidance by $0.10 to...

at 06:00
Avantor, Inc. , a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today reported financial results for its first...

at 05:12
Swedish Orphan Biovitrum AB (publ) (Sobi®) has established a medium term note programme with a framework amount of SEK 10 billion or the equivalent thereof in EUR (the "MTN Programme"). For this purpose, Sobi has prepared a base prospectus, which...



News published on and distributed by: